Splenic artery aneurysm

脾动脉瘤
  • 文章类型: Journal Article
    脾动脉瘤(SAAs)破裂与高死亡率相关。干预前后定期进行影像学监测对于指导最佳证据治疗至关重要。以下研究旨在确定彩色多普勒超声成像(DUS)与数字减影血管造影术(DSA)和磁共振血管造影术(MRA)的疗效,作为选择性线圈栓塞真实SAA后的随访方式。我们分析了20名患者的数据,15名女性(48.1±16.1岁)使用可分离的纤维栓塞线圈进行选择性SAA线圈栓塞。使用DUS成像,MRA,在初次栓塞或随后的再栓塞手术后3个月进行DSA。初级临床成功,定义为I类动脉瘤闭塞,在3个月的随访中观察到16例(80.0%)患者。与DSA和92.3%和30%相比,DUS的敏感性为94.4%,特异性为42.9%。分别,在识别I类动脉瘤闭塞时与MRA进行比较。DUS的阳性预测值(PPV)为75.0%,而DUS的净现值为90.5%。DUS在检测动脉瘤闭塞和临床成功方面显示出很高的灵敏度,同时表现出较差的特异性。尽管如此,谨慎,这种随访方式可用于监测选择性SAA栓塞后选择的低危患者.DUS可以提供更高的成本效益比,能够更系统的程序后后续行动,因为它与MRA相比更常用,与DSA相比是非侵入性的。
    Splenic artery aneurysm (SAAs) rupture is associated with a high mortality rate. Regular surveillance with imaging before and after intervention is crucial to guide best evidence treatment. The following study aimed to determine the efficacy of color Doppler ultrasound imaging (DUS) compared to digital subtraction angiography (DSA) and magnetic resonance angiography (MRA) as a follow-up modality after selective coil embolization of true SAAs. We analyzed data from 20 patients, 15 females (48.1 ± 16.1 years) undergoing selective SAA coil embolization using detachable fibered embolization coils. Imaging using DUS, MRA, and DSA was performed 3 months after the initial embolization or the consequent re-embolization procedure. Primary clinical success, defined as Class I aneurysm occlusion, on 3-month follow-up was seen in 16 (80.0%) patients. DUS had a sensitivity of 94.4% and a specificity of 42.9% when compared to DSA and 92.3% and 30%, respectively, when compared to MRA in identifying Class I aneurysm occlusion. The positive predictive value (PPV) of DUS in identifying the need for re-embolization was 75.0%, while the NPV of DUS in these terms was 90.5%. DUS showed a high sensitivity in detecting aneurysm occlusion and clinical success, simultaneously exhibiting poor specificity. Still, with caution, this follow-up modality could be used for monitoring select low-risk patients after selective embolization of SAAs. DUS could provide a higher cost-to-benefit ratio, enabling more systematic post-procedural follow-up, as it is far more commonly used compared to MRA and non-invasive compared to DSA.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:我们旨在评估双微导管技术治疗囊状脾动脉瘤的安全性和有效性。
    方法:从2013年11月至2020年10月,56例囊状脾动脉瘤患者在我们机构接受了双微导管技术的血管内治疗。技术上的成功定义为动脉瘤腔的栓塞,而没有阻塞父动脉。临床成功定义为没有因脾动脉瘤而死亡,没有再干预,1、6和12个月时复发或器官功能障碍。
    结果:技术成功率为100%。未观察到与血管造影或栓塞相关的主要并发症。轻微的并发症包括发烧,疼痛,恶心,13例患者出现轻微并发症。在1个月,临床成功率为96.4%。在6个月和12个月时,临床成功率为92.9%。没有动脉瘤复发或需要再干预。
    结论:双微导管技术线圈栓塞治疗囊状脾动脉瘤是一种安全有效的方法,为希望保留其原始血流动力学的患者提供了合理的选择。
    OBJECTIVE: We aimed to assess the safety and efficacy of the double microcatheter technique in the treatment of saccular splenic artery aneurysms.
    METHODS: From November 2013 to October 2020, 56 patients with saccular splenic artery aneurysms underwent endovascular treatment with the double microcatheter technique at our institution. Technical success was defined as embolization of the aneurysmal cavity with no obstruction of the parent artery. Clinical success was defined as no deaths due to splenic artery aneurysms, and no reintervention, recrudescence or organ dysfunction at 1, 6, and 12 months.
    RESULTS: The technical success rate was 100%. No major complications related to angiography or embolization were observed. Minor complications included fever, pain, and nausea, and 13 patients developed minor complications. At 1 month, the rate of clinical success was 96.4%. At 6 and 12 months, the clinical success rate was 92.9%. There were no aneurysmal recurrences or necessities of reintervention.
    CONCLUSIONS: Coil embolization with the double microcatheter technique is a safe and effective modality for treating saccular splenic artery aneurysms and offers a reasonable choice for patients who want to retain their original hemodynamics.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号